Rizatriptan Benzoate
- Product NDC
- 70518-4362
- 11-digit product format
- 705184362
- Labeler code
- 70518
- Product ID
- 70518-4362_37ed5715-4431-ba05-e063-6394a90a5e0a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rizatriptan Benzoate
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA203062
- Marketing category
- ANDA
- Marketing start
- 2025-06-18
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rizatriptan Benzoate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIZATRIPTAN BENZOATE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WR978S7QHH |
| Rxcui | 312837 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70518-4362-0 | Rizatriptan Benzoate | 3 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 3 | | 1 |
| 70518-4362-0 | Rizatriptan Benzoate | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70518-4362-0 | 70518436200 | 3 BLISTER PACK in 1 CARTON (70518-4362-0) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 3 blister pack | 2025-06-18 | No | No | Historical |